IGM Biosciences receives Nasdaq non-compliance notice for MVLS below $50M

IGM Biosciences, Inc.

Received Nasdaq notice on June 6, 2025, for MVLS below $50M minimum requirement.
Has 180 calendar days, until December 3, 2025, to regain compliance.
Must have MVLS close at $50M+ for 10 consecutive business days to cure.
If non-compliance persists, Nasdaq may initiate delisting; company can appeal or consider transfer to Nasdaq Capital Market.
Listing continues under 'IGMS' with no immediate effect on trading.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.